The FDA intends to award a single-source, firm-fixed-price contract to Leco Corporation for one Leco FP928 nitrogen/protein analyzer, including delivery, installation, training, warranty, and a maintenance plan. Performance of services will occur in Atlanta, GA, with system delivery required within 30 days after award and installation within two weeks of receipt. The base period of performance runs from August 1, 2026, through July 31, 2031, if all options are exercised. The estimated value is below the Simplified Acquisition Threshold, and no specific budget amount is provided. Interested parties must submit a quotation demonstrating their capability by July 29, 2026, at 12:00 PM ET.